Katharine Sarah Davidoff, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lost to Follow-Up | 1 | 2019 | 124 | 0.160 |
Why?
|
| Lymphoma, Primary Effusion | 1 | 2015 | 17 | 0.130 |
Why?
|
| Caspase 1 | 1 | 2015 | 227 | 0.120 |
Why?
|
| Pinocytosis | 1 | 2013 | 63 | 0.110 |
Why?
|
| Herpesvirus 8, Human | 1 | 2015 | 256 | 0.110 |
Why?
|
| Gene Products, pol | 1 | 2012 | 43 | 0.100 |
Why?
|
| Virus Latency | 1 | 2015 | 361 | 0.100 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 1078 | 0.100 |
Why?
|
| Sarcoma, Kaposi | 1 | 2015 | 376 | 0.100 |
Why?
|
| Gene Products, gag | 1 | 2012 | 318 | 0.090 |
Why?
|
| Antigens, Viral | 1 | 2015 | 995 | 0.090 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2010 | 102 | 0.080 |
Why?
|
| HIV Protease Inhibitors | 1 | 2012 | 430 | 0.080 |
Why?
|
| Endocytosis | 1 | 2013 | 955 | 0.080 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 5799 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2010 | 591 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3269 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2010 | 1281 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5520 | 0.050 |
Why?
|
| Peptides | 1 | 2013 | 4354 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 5366 | 0.050 |
Why?
|
| Myocardium | 1 | 2010 | 4788 | 0.030 |
Why?
|
| Kenya | 1 | 2019 | 757 | 0.030 |
Why?
|
| HIV-1 | 1 | 2012 | 6960 | 0.030 |
Why?
|
| Cytochalasin D | 1 | 2013 | 91 | 0.030 |
Why?
|
| Amiloride | 1 | 2013 | 116 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2015 | 303 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2015 | 730 | 0.030 |
Why?
|
| HIV Infections | 1 | 2019 | 17569 | 0.030 |
Why?
|
| Social Stigma | 1 | 2019 | 788 | 0.030 |
Why?
|
| Saquinavir | 1 | 2012 | 29 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 9614 | 0.030 |
Why?
|
| Retroviridae | 1 | 2013 | 846 | 0.020 |
Why?
|
| Infusions, Subcutaneous | 1 | 2010 | 43 | 0.020 |
Why?
|
| Ventricular Myosins | 1 | 2010 | 65 | 0.020 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2010 | 158 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2019 | 2697 | 0.020 |
Why?
|
| Cell Line | 2 | 2013 | 15597 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2010 | 404 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2019 | 3141 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2010 | 842 | 0.020 |
Why?
|
| Apoptosis | 2 | 2015 | 9521 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 1327 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 1752 | 0.010 |
Why?
|
| Fibrosis | 1 | 2010 | 2080 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2012 | 1982 | 0.010 |
Why?
|
| Binding Sites | 1 | 2010 | 6022 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5798 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9556 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 60050 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 11930 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 89154 | 0.010 |
Why?
|
| Humans | 4 | 2019 | 767998 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18345 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 23640 | 0.000 |
Why?
|
| Mice | 1 | 2010 | 82024 | 0.000 |
Why?
|
| Male | 1 | 2019 | 364638 | 0.000 |
Why?
|
| Female | 1 | 2019 | 397102 | 0.000 |
Why?
|
| Animals | 1 | 2010 | 169225 | 0.000 |
Why?
|